Advised for an early breast cancer treatment in women who have already been treated with surgery, radiation, and/or chemotherapy. This Tamoxifen Citrate reduces the risk of developing a more serious type of breast cancer in women who have had ductal carcinoma in situ (DCIS; a type of breast cancer that does not spread outside of the milk duct where it forms) and who have been treated with surgery and radiation.
Advantages:
How to Use:
![]() |
3S CORPORATION
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |